Progesterone for the Treatment of Traumatic Brain Injury III
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The ProTECT study will determine if intravenous (IV) progesterone (started within 4 hours of
injury and given for a total of 96 hours), is more effective than placebo for treating
victims of moderate to severe acute traumatic brain injury.
Phase:
Phase 3
Details
Lead Sponsor:
David Wright
Collaborators:
Medical University of South Carolina Neurological Emergencies Treatment Trials Network (NETT)